tiprankstipranks
Trending News
More News >
Roquefort Investments PLC (GB:ROQ)
:ROQ
UK Market
Advertisement

Roquefort Investments PLC (ROQ) Price & Analysis

Compare
3 Followers

ROQ Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

15.03%84.97%
15.03% Insiders
Mutual Funds
― Other Institutional Investors
84.97% Public Companies and
Individual Investors

ROQ FAQ

What was Roquefort Investments PLC’s price range in the past 12 months?
Roquefort Investments PLC lowest share price was 1.08p and its highest was 6.78p in the past 12 months.
    What is Roquefort Investments PLC’s market cap?
    Roquefort Investments PLC’s market cap is £2.20M.
      When is Roquefort Investments PLC’s upcoming earnings report date?
      Roquefort Investments PLC’s upcoming earnings report date is Sep 25, 2025 which is in 68 days.
        How were Roquefort Investments PLC’s earnings last quarter?
        Currently, no data Available
        Is Roquefort Investments PLC overvalued?
        According to Wall Street analysts Roquefort Investments PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Roquefort Investments PLC pay dividends?
          Roquefort Investments PLC does not currently pay dividends.
          What is Roquefort Investments PLC’s EPS estimate?
          Roquefort Investments PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Roquefort Investments PLC have?
          Roquefort Investments PLC has 157,444,030 shares outstanding.
            What happened to Roquefort Investments PLC’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Roquefort Investments PLC?
            Currently, no hedge funds are holding shares in GB:ROQ

            Company Description

            Roquefort Investments PLC

            Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
            Similar Stocks
            Company
            Price & Change
            Follow
            Amur Minerals
            Evgen Pharma
            Nuformix Plc
            Physiomics
            ValiRx plc
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis